News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
71,311 Results
Type
Article (1929)
Company Profile (3)
Press Release (69379)
Section
Business (21464)
Career Advice (9)
Deals (4553)
Drug Development (8165)
FDA (1804)
Job Trends (800)
News (37027)
Policy (3561)
Tag
Academia (94)
Allergies (11)
Alliances (8165)
ALS (9)
Alzheimer's disease (144)
Antibody-drug conjugate (ADC) (40)
Approvals (1869)
Artificial intelligence (20)
Autoimmune disease (8)
Automation (1)
Bankruptcy (8)
Best Places to Work (585)
Biosimilars (48)
Biotechnology (5)
Bladder cancer (22)
Brain cancer (5)
Breast cancer (42)
Cancer (396)
Cardiovascular disease (13)
Career advice (9)
CAR-T (9)
Cell therapy (40)
Cervical cancer (2)
Clinical research (7295)
Collaboration (182)
Compensation (16)
Complete response letters (4)
COVID-19 (193)
C-suite (41)
Cystic fibrosis (4)
Data (447)
Depression (7)
Diabetes (27)
Diagnostics (612)
Digital health (3)
Drug discovery (25)
Duchenne muscular dystrophy (23)
Earnings (7834)
Events (7218)
Executive appointments (58)
FDA (2100)
Fibrodysplasia Ossificans Progressiva (1)
Funding (98)
Gene editing (4)
Gene therapy (27)
GLP-1 (60)
Government (233)
Grass and pollen (1)
Guidances (37)
Healthcare (1079)
HIV (1)
Huntington's disease (2)
IgA nephropathy (15)
Immunology and inflammation (4)
Indications (7)
Infectious disease (204)
Inflammatory bowel disease (20)
Inflation Reduction Act (1)
Influenza (9)
Intellectual property (24)
IPO (1636)
Job creations (241)
Job search strategy (9)
Layoffs (6)
Legal (953)
Liver cancer (17)
Lung cancer (77)
Lymphoma (26)
Manufacturing (62)
MASH (11)
Medical device (1140)
Medtech (1142)
Mergers & acquisitions (3054)
Metabolic disorders (63)
Multiple sclerosis (12)
NASH (1)
Neurodegenerative disease (14)
Neuroscience (229)
NextGen: Class of 2025 (220)
Non-profit (63)
Obesity (21)
Opinion (1)
Ovarian cancer (19)
Pain (6)
Pancreatic cancer (11)
Parkinson's disease (26)
Partnered (2)
Patents (39)
Patient recruitment (31)
Peanut (1)
People (5042)
Pharmaceutical (3)
Pharmacy benefit managers (2)
Phase I (1970)
Phase II (3075)
Phase III (2763)
Pipeline (293)
Policy (1)
Postmarket research (241)
Preclinical (686)
Press Release (2)
Prostate cancer (15)
Radiopharmaceuticals (22)
Rare diseases (43)
Real estate (603)
Regulatory (2745)
Reports (6)
Research institute (97)
RNA editing (1)
RSV (2)
Schizophrenia (12)
Series A (20)
Series B (16)
Service/supplier (1)
Sickle cell disease (3)
Spinal muscular atrophy (4)
Sponsored (1)
Startups (423)
Stomach cancer (1)
Supply chain (12)
Vaccines (35)
Venture capital (2)
Weight loss (4)
Women's health (2)
Date
Last 7 days (54)
Last 30 days (212)
Last 365 days (2671)
2025 (2215)
2024 (3253)
2023 (3820)
2022 (7012)
2021 (6373)
2020 (5874)
2019 (3864)
2018 (3014)
2017 (3560)
2016 (3171)
2015 (4030)
2014 (3020)
2013 (2600)
2012 (2775)
2011 (2902)
2010 (2663)
Location
Africa (85)
Alabama (3)
Arizona (9)
Asia (21774)
Australia (2451)
California (537)
Canada (317)
China (298)
Colorado (4)
Connecticut (18)
Delaware (4)
Europe (12811)
Florida (46)
Georgia (11)
Illinois (22)
India (26)
Indiana (11)
Japan (177)
Kansas (5)
Louisiana (1)
Maine (4)
Maryland (102)
Massachusetts (386)
Michigan (5)
Minnesota (32)
Missouri (3)
Nebraska (1)
Nevada (5)
New Hampshire (1)
New Jersey (316)
New York (195)
North Carolina (73)
Northern California (219)
Ohio (3)
Oregon (1)
Pennsylvania (92)
Rhode Island (1)
South America (107)
Southern California (250)
Tennessee (1)
Texas (45)
United States (1992)
Utah (17)
Virginia (39)
Washington D.C. (3)
Washington State (31)
Wisconsin (6)
71,311 Results for "chemomab ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Chemomab Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference
August 22, 2025
·
2 min read
Press Releases
Chemomab Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update
August 15, 2025
·
15 min read
Press Releases
Chemomab Announces New Medical and Clinical Appointments
April 16, 2025
·
9 min read
Press Releases
Chemomab Announces Oral Presentation of Positive Nebokitug Phase 2 Clinical Data in Primary Sclerosing Cholangitis at BSG Live’25
July 1, 2025
·
8 min read
Press Releases
Chemomab Therapeutics to Present Nebokitug Clinical Data at Upcoming Scientific Conferences
April 21, 2025
·
3 min read
Press Releases
Chemomab Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update
May 15, 2025
·
15 min read
Press Releases
New Data Presented at CORA 2025 Conference Highlights Clinical Potential of Chemomab’s Nebokitug in Systemic Sclerosis
March 7, 2025
·
11 min read
Chemomab Therapeutics to Participate in Upcoming Scientific Conferences - May 17, 2024
Chemomab Therapeutics Ltd. today announced upcoming scientific presentations at the Gordon Research Conference on Chemotactic Cytokines and at EASL 2024, the Annual Congress of the European Association for the Study of the Liver.
May 17, 2024
·
3 min read
Press Releases
Chemomab Reports Positive Feedback From Two Recent FDA Meetings Supporting Phase 3 Advancement of Nebokitug in Primary Sclerosing Cholangitis
June 11, 2025
·
8 min read
Business
Chemomab Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update
Chemomab Therapeutics Ltd. announced the company will report its first quarter 2024 financial results and provide a business update on May 9, 2024, at 7:00 am Eastern Time.
April 24, 2024
·
1 min read
1 of 7,132
Next
